Approximately 40% of families fulfilling the clinical criteria for HDGC have germline CDH1 mutations.5 A subset of the remaining families of HDGC, and ones fulfilling the criteria of other familial GC, harbor pathogenic germline mutation in other genes that are associated with hereditary cancer predisposition syndromes.4 This evidence concerns the gene CDH1 and Familial gastric cancer.